Peptide profile
Thymosin Alpha-1
Thymus peptide for immune system enhancement
Compare Thymosin Alpha-1 with other peptides →Summary
A helper that makes your body's defense team stronger to fight off sickness.
- Typical dose
- 1.6mg Twice weekly (3-4 days apart)
- Route
- Subcutaneous
- Cycle length
- 4 weeks to 6 months
- Evidence
- Limited human data
Mechanism
How it works
Thymosin alpha-1 acts like boot camp training for your T-cells — it drills, strengthens, and deploys your immune system's special forces.
Synthetic acetylated polypeptide enhancing cell-mediated immunity by promoting T-cell differentiation and maturation.
Reported in research
Benefits
- Makes your body's defense cells work better
- Helps vaccines work even better
- Used to help treat a long-lasting liver illness called hepatitis B
Context, not a prescription
Dosing
- Typical range
- 1.6mg Twice weekly (3-4 days apart) (Subcutaneous)
- Cycle length
- 4 weeks to 6 months
Safety
Side effects & contraindications
Possible side effects
- Injection site pain
- Mild fatigue
- Low-grade fever
- Transient muscle atrophy
- Joint pain
- Rash
Contraindications
- Autoimmune disease flare-ups
- Organ transplant recipients
- Pregnancy or breastfeeding
Research information, not medical advice. Always consult a licensed clinician before considering any peptide.
In depth
Full profile
What it does
Your body watches for germs better, vaccines work better, and you get sick less often.
How it works
Thymosin alpha-1 is like a training camp for your defense cells. It teaches them, makes them tough, and sends them to protect you.
It talks to special buttons on your defense cells to turn on your body's protection.
What to expect
You feel it helping your defenses in 1-2 weeks. The best results come by 4 weeks.
- Weeks 1-2: Your defense system starts waking up.
- Weeks 4-8: Your defense cells get stronger and vaccines work better.
- Months 3-6: You get the biggest boost to your defense system.
Good to know
- Use a different spot each time you give the shot
- Watch for signs your body is attacking itself
- Keep everything clean and germ-free
Staying safe
- Sore spot where you got the shot
- Feeling a little tired
- A small fever
Avoid if you have:
- People whose body is attacking itself right now
- People who got a new organ from a donor
- Women who are pregnant or breastfeeding
Mechanism of action
Synthetic acetylated polypeptide enhancing cell-mediated immunity by promoting T-cell differentiation and maturation.
Interacts with Toll-like receptors (TLR2 and TLR9) on immune cells to activate innate immunity.
Pharmacodynamics
Immune effects within 1-2 weeks; maximum benefit by 4 weeks.
Enhanced immune surveillance, improved vaccine response, reduced infection frequency.
Timeline
- Weeks 1-2: Initial immune system activation.
- Weeks 4-8: Enhanced T-cell function and vaccine response.
- Months 3-6: Maximum immunomodulatory benefit.
Comparisons
- Thymosin Alpha-1 — effectiveness High, safety Excellent, cost $$, Easy to use
- LL-37 — effectiveness Emerging, safety Emerging, cost $$, Medium to use
Adverse effects
Common:
- Injection site pain
- Mild fatigue
- Low-grade fever
Rare:
- Transient muscle atrophy
- Joint pain
- Rash
Contraindications & risk mitigation
Contraindicated in:
- Autoimmune disease flare-ups
- Organ transplant recipients
- Pregnancy or breastfeeding
- Rotate injection sites
- Monitor for autoimmune symptoms
- Use sterile technique
Qué hace
Your body watches for germs better, vaccines work better, and you get sick less often.
Cómo funciona
Thymosin alpha-1 is like a training camp for your defense cells. It teaches them, makes them tough, and sends them to protect you.
It talks to special buttons on your defense cells to turn on your body's protection.
Qué esperar
You feel it helping your defenses in 1-2 weeks. The best results come by 4 weeks.
- Weeks 1-2: Your defense system starts waking up.
- Weeks 4-8: Your defense cells get stronger and vaccines work better.
- Months 3-6: You get the biggest boost to your defense system.
Bueno saber
- Use a different spot each time you give the shot
- Watch for signs your body is attacking itself
- Keep everything clean and germ-free
Manteniéndose seguro
- Sore spot where you got the shot
- Feeling a little tired
- A small fever
Evitar si tienes:
- People whose body is attacking itself right now
- People who got a new organ from a donor
- Women who are pregnant or breastfeeding
Mecanismo de acción
Synthetic acetylated polypeptide enhancing cell-mediated immunity by promoting T-cell differentiation and maturation.
Interacts with Toll-like receptors (TLR2 and TLR9) on immune cells to activate innate immunity.
Farmacodinamia
Immune effects within 1-2 weeks; maximum benefit by 4 weeks.
Enhanced immune surveillance, improved vaccine response, reduced infection frequency.
Cronología
- Weeks 1-2: Initial immune system activation.
- Weeks 4-8: Enhanced T-cell function and vaccine response.
- Months 3-6: Maximum immunomodulatory benefit.
Comparaciones
- Thymosin Alpha-1 — efectividad High, seguridad Excellent, costo $$, Easy de usar
- LL-37 — efectividad Emerging, seguridad Emerging, costo $$, Medium de usar
Efectos adversos
Comunes:
- Injection site pain
- Mild fatigue
- Low-grade fever
Raros:
- Transient muscle atrophy
- Joint pain
- Rash
Contraindicaciones y mitigación de riesgos
Contraindicado en:
- Autoimmune disease flare-ups
- Organ transplant recipients
- Pregnancy or breastfeeding
- Rotate injection sites
- Monitor for autoimmune symptoms
- Use sterile technique
Reference data
Specifications
- Route
- Subcutaneous
- Cycle length
- 4 weeks to 6 months
FAQ
Common questions
What is thymosin alpha-1 used for?
Primarily for chronic hepatitis B and as an immune enhancer for vaccines.
Can it be injected intramuscularly?
No, it should only be given subcutaneously — not IM or IV.
What is the evidence level?
This compound is classified as Limited human data. Some human data exists but trials are small, short-term, or not yet replicated.
Research
Research & sources
Current evidence for Thymosin Alpha-1 is rated as Limited human data. Limited human data is available.
- 1. Thymosin alpha-1 in hepatitis B (2012) — DOI:10.1002/14651858.CD008443.pub2
- 2. Immune modulation by TA1 (2017) — DOI:10.1080/10245332.2017.1316088
- 3. Thymosin alpha-1 in hepatitis B (2012)
- 4. Immune modulation by TA1 (2017)